|
|
|
|
Stem Cell Agency Officer Finds Work in San Diego
The state stem cell agency's chief scientific officer has left the agency for a job with startup San Diego biotech Organovo, the company said March 16.Marie Csete spent the last two years leading the California Institute for Regenerative Medicine's stem cell...
|
|
|
FDA Seeks Info, Amylin Sees Clear Path to Drug Approval
Amylin Pharmaceuticals Inc.said March 15 it will have to address some key concerns raised by the U.S. Food and Drug Administration before its once-weekly diabetes drug passes the agencys requirements for approval.The San Diego biotech said it received a...
|
|
|
FDA Seeks Info, Amylin Sees Clear Path to Drug Approval
Amylin Pharmaceuticals Inc.said March 15 it will have to address some key concerns raised by the U.S. Food and Drug Administration before its once-weekly diabetes drug passes the agencys requirements for approval.The San Diego biotech said it received a...
|
|
|
FDA Seeks Info, Amylin Sees 'Clear Path' to Drug Approval
Amylin Pharmaceuticals Inc.said March 15 it will have to address some key concerns raised by the U.S. Food and Drug Administration before its once-weekly diabetes drug passes the agency's requirements for approval. The San Diego biotech said it received...
|
|
|
Startup Targets Rare Genetic Disorder With New Drug
Afraxis, a fledgling San Diego drug developer with technology spun out of the Massachusetts Institute of Technology, has quietly been raising money the last couple of years for testing a new treatment for Fragile X syndrome.The genetic disorder, named after...
|
|
|
Life Tech to Help Unravel Genetic Clues in Quest for Cancer Treatment
A first-of-its-kind study that aims to decode the genetic makeup of an aggressive form of breast cancer will leverage Life Technologies Corp.s next-generation gene sequencing machine, known as the SOLiD System.On March 5, Life Tech announced it would join U...
|
|
|
Biotech's Changing Dynamics Widen Its Geographical Circle
Joe Panetta, president and CEO of life sciences trade group BIOCOM, sees the concentration of biotech in and around UC San Diego and La Jolla break up as more life sciences firms locate in diverse areas of the county.Photo by Michael S. Domine By SYLVIA...
|
|
|
Region's Biomedical Sector a Growth Leader in California
By MARION WEBB Indications are good that San Diego's innovative biomedical industry will create more startup companies and jobs this year, but access to venture capital funding continues to be a major challenge for early stage firms, according to local biotech...
|
|
|
Slumping Biotechs Leave Trail of Vacant Lab Space Behind
By MARK LARSON Four areas of San Diego have the most vacant laboratory space available for biotech companies, and those vacancies are the fallout of tough economic times.'Torrey Pines is the most desirable in terms of image and location,' said Scot Ginsburg,...
|
|
|
Innovation as Abundant as Patent Diversity Across Local Landscape
By MARTY GRAHAM A map of San Diego's more than 15,000 patents issued since 1976 weighs heavily on the La Jolla/Golden Triangle/Sorrento Valley area, and the more than 5,600 pending patent applications follow that trend, according to a search based on patent...
|
